The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Subjects With Chronic Stable Angina: A Phase 4 Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study
Phase of Trial: Phase IV
Latest Information Update: 16 Apr 2016
At a glance
- Drugs Febuxostat (Primary)
- Indications Angina pectoris
- Focus Pharmacodynamics
- Sponsors Takeda; Takeda Global Research and Development Center
- 10 Mar 2016 Status changed from active, no longer recruiting to completed.
- 07 Jan 2015 Planned End Date changed from 1 Sep 2014 to 1 Apr 2015 according to ClinicalTrials.gov record.
- 07 Jan 2015 Planned primary completion date changed from 1 Sep 2014 to 1 Apr 2015 according to ClinicalTrials.gov record.